Nu Nwe Tun
Geriatric Medicine · Hermiston, ORNPI 1942685466
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$357
- AbbVie$343
- AstraZeneca$337
- Bayer$231
- Novo Nordisk$229
- Novartis$181
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 16 | $357 |
| AbbVie | 13 | $343 |
| AstraZeneca(2 entities) | 18 | $337 |
| Bayer | 14 | $231 |
| Novo Nordisk | 14 | $229 |
| Novartis | 10 | $181 |
| Amarin Pharma, Inc. | 12 | $159 |
| Otsuka America Pharmaceutical, Inc. | 6 | $121 |
| Sanofi Pasteur Inc. | 4 | $102 |
| Lilly USA, LLC | 5 | $94 |
| Sanofi-aventis U.S. LLC | 4 | $93 |
| GSK | 4 | $84 |
| Xeris Pharmaceuticals, Inc. | 4 | $67 |
| Amgen | 3 | $58 |
| Ascendis Pharma Endocrinology Inc | 2 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $46 |
| Medtronic | 3 | $43 |
| Rhythm Pharmaceuticals, Inc. | 2 | $39 |
| Mylan Specialty L.p. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Pfizer | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
How this compares
$2,912 in reported general payments places this provider in the 95th percentile of 35 geriatric medicine providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ForteoTeriparatide | 22 | $97,163 |
| JardianceEmpagliflozin | 94 | $91,562 |
| EliquisApixaban | 112 | $87,988 |
| TrulicityDulaglutide | 66 | $69,934 |
| OzempicSemaglutide | 67 | $69,876 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 69 | $49,058 |
| FarxigaDapagliflozin Propanediol | 46 | $40,312 |
| RexultiBrexpiprazole | 21 | $27,474 |
| MyrbetriqMirabegron | 48 | $26,017 |
| RybelsusSemaglutide | 18 | $21,751 |
| XareltoRivaroxaban | 16 | $11,207 |
| LinzessLinaclotide | 17 | $9,700 |
| Incruse ElliptaUmeclidinium Bromide | 25 | $8,764 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $8,593 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $6,940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCForteo, Trulicity | $94 | $167,09888 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $357 | $98,502107 claims |
| Novo NordiskOzempic, Rybelsus | $229 | $91,62685 claims |
| PfizerEliquis | $35 | $87,988112 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta, Arnuity Ellipta | $84 | $72,426132 claims |
| AstraZenecaFarxiga | $337 | $40,31246 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $121 | $27,47421 claims |
| Astellas Pharma US IncMyrbetriq | $19 | $26,01748 claims |
| AbbVieLinzess, Synthroid | $343 | $11,80135 claims |
| Johnson & JohnsonXarelto | $23 | $11,20716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 35 geriatric medicine providers in Oregon.
Other geriatric medicine in Hermiston
- Jitendra PatelBrookings$2K
- Samuel SukBeaverton$456
- Ranganathan RajendranRoseburg$435
- John WilliamsMcMinnville$236
- Maria Angela GalangMcMinnville$165
- John RobertsEugene$146
- Irma MoodyEugene$130
- Margaret NjonjoEugene$122
- Elizabeth FloresTualatin$114
- Marian HodgesPortland$114
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.